Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:12 AM
Study NCT ID:
NCT00742105
Status:
TERMINATED
Last Update Posted:
2018-09-25
First Post:
2008-08-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-25
First Submit QC Date:
None
Study First Post Date:
2008-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-21
Last Update Post Date:
2018-09-25
Last Update Post Date Type:
ACTUAL